View all dosages and compare prices:

💊 Buy Mounjaro — all dosages →
💉KwikPen · Eli Lilly

Buy Mounjaro 2.5 mg

Weight loss program start — body adaptation

in Ukraine · Original Eli Lilly (UK) · Thermobox delivery

17 000₴

💊 Try for 8 000 ₴/mo

4 individual doses instead of a full pen · save 9 000 ₴

In stock

Ships today · before 15:00

Delivery Mon, Sep 28 · Nova Poshta

Starter Mounjaro pen 2.5 mg for beginning your weight loss program. Minimum dose for gentle body adaptation to tirzepatide.

In short: Mounjaro 2.5 mg

Price: 17 000 ₴. ≈ 4 250 ₴ per injection — 4 doses per KwikPen. In stock. Delivery across Ukraine — Nova Poshta, 1–3 days; Kyiv — courier, 1–2 hours. Cold chain 2–8°C. 24/7 specialist support included in the price. Order on the official DOZA website: doza.clinic.

Dosage2.5 mg
Recommended weeksWeeks 1-4
Course4 weeks
Dosage2.5 mg once weekly subcutaneous
Method💉 KwikPen
💡

Starting dose. Minimal risk of discomfort. After 4 weeks, your specialist will increase the dose to 5 mg.

👨‍⚕️

Specialist support included in the price

A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.

🇬🇧

DOZA offers the original UK version of Mounjaro 2.5 mg

Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Each pen has a GS1 DataMatrix with serial number and batch number.

✓Original Eli Lilly (Made in U.K.) — GS1 DataMatrix
✓Serial number verification — authenticity confirmed
✓Thermobox +2…+8°C — cold chain unbroken
✓Specialist support 24/7 — throughout the program

DOZA supplies original Mounjaro by Eli Lilly (Made in U.K.) with full cold chain compliance at 2–8°C from warehouse to client. Each KwikPen has a GS1 DataMatrix with serial number and date.

Free specialist consultation

Benefits of Mounjaro 2.5 mg

  • ✓Gentle body adaptation — minimal discomfort risk
  • ✓Appetite reduction from first days of treatment
  • ✓Median first-month result in the DOZA report: −4.8 kg (38 cases)
  • ✓Original Eli Lilly product with verified serial number
  • ✓Convenient KwikPen — 30-second application
  • ✓24/7 DOZA specialist support

Mounjaro 2.5 mg — detailed description

Mounjaro 2.5 mg is the starter dose of the original Eli Lilly product for the first month of the programme. The KwikPen holds 4 doses of 2.5 mg tirzepatide — one injection per week.

This dose exists for a gentle adaptation to the dual GLP-1 and GIP action. Most clients notice a clear drop in appetite within the first days.

The DOZA report puts the median first-month result at −4.8 kg (38 cases, self-reported by clients). After successful adaptation the specialist raises the dose to 5 mg.

How Mounjaro 2.5 mg works — tirzepatide mechanism of action

Tirzepatide at 2.5 mg dose activates GLP-1 and GIP receptors — two key pathways for appetite and metabolism regulation. Even at minimum dose, the dual mechanism provides:

• Appetite reduction through hypothalamic action

• Delayed gastric emptying — food provides satiety feeling longer

• Beginning of fat reserve mobilization through GIP receptors

The starting dose allows the body to gradually adapt to the product, minimizing discomfort risk.

Clinical research

Mounjaro (tirzepatide 2.5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.

View full clinical research database →

Titration protocol to 2.5 mg (tirzepatide)

Weeks 1–4
2.5 mg← this dose

The only FDA-approved starting dose

Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 2.5 mg: titration dose (4 weeks) (based on clinical studies).

Who is Mounjaro 2.5 mg for

  • Starting Mounjaro therapy — the mandatory first step for all patients
  • Gastrointestinal adaptation before moving up to 5 mg
  • Patients with increased sensitivity to GLP-1 medications

Mounjaro 2.5 mg — compared to other doses

  • 2.5 mg is a starting dose: the goal of the first month is adaptation, not maximum effect
  • After 4 weeks it must be increased to 5 mg
  • In SURMOUNT-1, 2.5 mg was used for 4 weeks as a titration step before escalation

Frequently asked questions about Mounjaro 2.5 mg

Valentyna Tytorenko

The starting dose of 2.5 mg allows the body to adapt to tirzepatide with minimal discomfort risk. This is Eli Lilly's manufacturer recommendation and standard protocol. Moving directly to higher doses is not recommended.

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Ready to start?

Free specialist consultation

Weight loss program — step-by-step dose escalation

Mounjaro 2.5 mg — buy in Ukraine from DOZA

Mounjaro 2.5 mg (Mounjaro 2,5 mg, tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 17 000 ₴ (≈ 4 250 ₴ per injection). Buy Mounjaro 2.5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).

Why does DOZA only work with the UK version? DOZA supplies original Mounjaro by Eli Lilly (Made in U.K.) with full cold chain compliance at 2–8°C. Each KwikPen has a GS1 DataMatrix — serial number, manufacturing date and batch number. Serial number photos available upon request before shipping.

Mounjaro 2.5 mg is suitable for weeks 1-4 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.

DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 2.5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.

Information verified

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Melnyk Natalia

Gastroenterologist

⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.